TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of diabetes mellitus type II

Links shared publicly online about this topic.

486
total visits

TransPharma completes ViaDor-GLP1 agonist Phase 1b trial for treatment of diabetes mellitus type II

TransPharma Medical Ltd., a specialty pharmaceutical company focused on the development and commercialization of drug products utilizing a proprietary active transdermal drug delivery technology, announced today the successful completion of a Phase 1b trial of ViaDor-GLP1 agonist, which is being developed for the treatment of diabetes mellitus type II.

View full resource at news-medical.net

Tags: Diabetes, Drug, Pharma, Medical